Developing a tool to assess the health-related quality of life in calves with respiratory disease: tool refinement and construct validity testing

Autor: Bell, D.J., Duthie, C-A., Mason, C.S., Hancock, A., Penny, C., Odeyemi, I., Bartram, D.J., Haskell, M.J.

Publikováno v: In animal November 2024 18(11)

Conceptualisation and Role of Market Access in Pharmaceutical Industry: A Scoping Review.

Autor: Fatoye C; Department of Health and Social Care, University Campus Oldham, Oldham OL1 1BB, UK; clara.fatoye@oldham.ac.uk.; Department of Health Professions, Manchester Metropolitan University, Manchester M15 6BH, UK; g.yeowell@mmu.ac.uk (G.Y.); iodeyemi@aol.com (I.O.)., Yeowell G; Department of Health Professions, Manchester Metropolitan University, Manchester M15 6BH, UK; g.yeowell@mmu.ac.uk (G.Y.); iodeyemi@aol.com (I.O.)., Miller E; School of Nursing and Public Health, Manchester Metropolitan University, Manchester M15 6BH, UK; e.miller@mmu.ac.uk., Odeyemi I; Department of Health Professions, Manchester Metropolitan University, Manchester M15 6BH, UK; g.yeowell@mmu.ac.uk (G.Y.); iodeyemi@aol.com (I.O.)., Mbada C; Department of Health Professions, Manchester Metropolitan University, Manchester M15 6BH, UK; g.yeowell@mmu.ac.uk (G.Y.); iodeyemi@aol.com (I.O.).

Publikováno v: Journal of market access & health policy [J Mark Access Health Policy] 2024 May 01; Vol. 12 (2), pp. 81-99. Date of Electronic Publication: 2024 May 01 (Print Publication: 2024).

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

An optimized purification protocol for enzymatically synthesized S-adenosyl-L-methionine (SAM) for applications in solution state infrared spectroscopic studies.

Autor: Odeyemi I; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Douglas TA; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Igie NF; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Hargrove JA; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Hamilton G; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Bradley BB; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Thai C; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Le B; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Unjia M; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Wicherts D; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Ferneyhough Z; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Pillai A; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Koirala S; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Hagge LM; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Polara H; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Trievel RC; University of Michigan, 1150 W. Medical Center Dr., Ann Arbor, 48109, MI, USA., Fick RJ; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA., Stelling AL; The University of Texas at Dallas, 800 W. Campbell Rd., Richardson, 75080, TX, USA. Electronic address: stelling@utdallas.edu.

Publikováno v: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Mar 15; Vol. 309, pp. 123816. Date of Electronic Publication: 2024 Jan 02.

Budget impact of switching from an immediate-release to a prolonged-release formulation of tacrolimus in renal transplant recipients in the UK based on differences in adherence

Autor: Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF

Publikováno v: Patient Preference and Adherence, Vol 2014, Iss default, Pp 391-399 (2014)

Gorden Muduma,1 Isaac Odeyemi,1 Jayne Smith-Palmer,2 Richard F Pollock21Astellas Pharma Europe, Chertsey, UK; 2Ossian Health Economics and Communications, Basel, SwitzerlandBackground and aims: Advagraf is a once-daily prolonged-release formulation o

Externí odkaz: https://doaj.org/article/2deae2c626574e8db3fa98b266a9f168